Barclays raised the firm’s price target on Argenx (ARGX) to EUR 880 from EUR 850 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Immunovant upgraded to Outperform at Wolfe on improving Graves’ perception
- argenx: Leadership Continuity and Pipeline Milestones Underpin Sustained Buy Rating and $1,006 Price Target
- argenx: Leadership Transition, Pipeline Strength, and Commercial Expansion Support Buy Rating and $915 Target
- Argenx Unveils CEO Succession as Co‑Founder Moves to Chair Role
- Argenx CEO Tim Van Hauwermeiren to transition to chair, Karen Massey to succeed